{"result": "(\"entity\"<|>MILLION M<|>PERSON<|>Million M is an author who contributed to research on gut bacteria and obesity, highlighting the relationship between gut microbiota and metabolic outcomes.)\n##\n(\"entity\"<|>WU GD<|>PERSON<|>Wu GD is a researcher who studied the link between long-term dietary patterns and gut microbial enterotypes.)\n##\n(\"entity\"<|>CANI PD<|>PERSON<|>Cani PD is a researcher who has explored the role of gut microbiota in energy metabolism and metabolic diseases.)\n##\n(\"entity\"<|>MOORE PR<|>PERSON<|>Moore PR is an author who investigated the use of antibiotics in nutritional studies.)\n##\n(\"entity\"<|>GARLY M-L<|>PERSON<|>Garly M-L is a researcher who studied the effects of prophylactic antibiotics on preventing pneumonia and other complications after measles.)\n##\n(\"entity\"<|>MURPHY R<|>PERSON<|>Murphy R is an author who examined the impact of antibiotic treatment during infancy on body mass index.)\n##\n(\"relationship\"<|>MILLION M<|>GUT MICROBIOTA<|>Million M's research discusses the relationship between gut bacteria and obesity, emphasizing the importance of gut microbiota in metabolic health.<|>7)\n##\n(\"relationship\"<|>WU GD<|>GUT MICROBIOTA<|>Wu GD's studies link dietary patterns with gut microbial enterotypes, showing how diet influences gut microbiota composition.<|>8)\n##\n(\"relationship\"<|>CANI PD<|>GUT MICROBIOTA<|>Cani PD's research highlights the role of gut microbiota in energy metabolism and its implications for metabolic diseases.<|>8)\n##\n(\"relationship\"<|>MOORE PR<|>GUT MICROBIOTA<|>Moore PR's work on antibiotics in nutritional studies relates to how gut microbiota can be affected by antibiotic use.<|>6)\n##\n(\"relationship\"<|>GARLY M-L<|>GUT MICROBIOTA<|>Garly M-L's research on antibiotics and their effects on health outcomes connects to the role of gut microbiota in preventing complications.<|>6)\n##\n(\"relationship\"<|>MURPHY R<|>GUT MICROBIOTA<|>Murphy R's findings on antibiotic treatment during infancy relate to changes in gut microbiota and subsequent body mass index.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: barrier function and metabolic outcomes. J Nutr                        J. 2008;22(7):2416-26.\n      Biochem. 2014;25(3):270-80.                                      50.   Million M, Lagier J-C, Yahav D, Paul M. Gut bacte-\n37.   Wu GD, Chen J, Hoffmann C, Bittinger K, Chen                           rial microbiota and obesity. Clin Microbiol Infect.\n      Y-Y, Keilbaugh SA, et al. Linking long-term dietary                    2013;19(4):305-13.\n      patterns with gut microbial enterotypes. Science.                51.   Moore PR, Evenson A. Use of sulfasuxidine, strep-\n      2011;334(6052):105-8.                                                  tothricin, and streptomycin in nutritional studies\n38.   Cani PD, Delzenne NM. The role of the gut micro-                       with the chick. J Biol Chem. 1946;165(2):437-41.\n      biota in energy metabolism and metabolic disea-                  52.   Trasande L, Blustein J, Liu M, Corwin E, Cox LM,\n      se. Curr Pharm Des. 2009;15(13):1546-58.                               Blaser MJ. Infant antibiotic exposures and early-life\n39.   Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin                        body mass. Int J Obes 2005. 2013;37(1):16-23.\n      RG, Tuohy KM, et al. Selective increases of bifido-              53.   Southern KW, Barker PM, Solis-Moya A, Patel L.\n      bacteria in gut microflora improve high-fat-diet-in-                   Macrolide antibiotics for cystic fibrosis. Cochrane\n      duced diabetes in mice through a mechanism                             Database Syst Rev. 2011;(12):CD002203.\n      associated      with     endotoxaemia.         Diabetologia.     54.   Garly M-L, Balé C, Martins CL, Whittle HC, Nielsen\n      2007;50(11):2374-83.                                                   J, Lisse IM, et al. Prophylactic antibiotics to prevent\n40.   Xiao S, Zhao L. Gut microbiota-based translational                     pneumonia and other complications after meas-\n      biomarkers to prevent metabolic syndrome via nu-                       les: community based randomised double blind\n      tritional    modulation.        FEMS       Microbiol      Ecol.        placebo controlled trial in Guinea-Bissau. BMJ.\n      2014;87(2):303-14.                                                     2006;333(7581):1245.\n41.   Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart              55.   Murphy R, Stewart AW, Braithwaite I, Beasley R,\n      C, Bindels LB, et al. Cross-talk between Akkerman-                     Hancox RJ, Mitchell EA, et al. Antibiotic treatment\n      sia muciniphila and intestinal epithelium controls                     during infancy and increased body mass index in\n      diet-induced obesity. Proc Natl Acad Sci U S A.                        boys: an international cross-sectional study. Int J\n      2013;110(22):9066-71.                                                  Obes 2005. 2014;38(8):1115-9.\n---\n                                                                             Tema 11.    Microbiota intestinal y obesidad           183\n\n\n\n56.  Luoto R, Kalliomäki M, Laitinen K, Isolauri E. The                   sease. J Gastroenterol Hepatol. 2008;23 Suppl\n     impact of perinatal probiotic intervention on the                    2:S278-285.\n     development        of   overweight      and    obesity:    fo-  68.  Klindworth A, Pruesse E, Schweer T, Peplies J,\n     llow-up study from birth to 10 years. Int J Obes.                    Quast C, Horn M, et al. Evaluation of general 16S\n     2010;34(10):1531-7.                                                  ribosomal RNA gene PCR primers for classical and\n57.  Dao MC, Everard A, Aron-Wisnewsky J, Sokolovs-                       next-generation sequencing-based diversity stu-\n     ka N, Prifti E, Verger EO, et al. Akkermansia mu-                    dies. Nucleic Acids Res. 2013;41(1):e1.\n     ciniphila and improved metabolic health during a                69.  Moran CP, Shanahan F. Gut microbiota and obesity:\n     dietary intervention in obesity: relationship with                   role in aetiology and potential therapeutic target. Best\n     gut   microbiome        richness     and    ecology.     Gut.        Pract Res Clin Gastroenterol. 2014;28(4):585-97.\n     2016;65(3):426-36.                                              70.  Tilg H. Obesity, metabolic syndrome, and micro-\n58.  Thuny F, Richet H, Casalta J-P, Angelakis E, Habib                   biota: multiple interactions. JClin Gastroenterol.\n     G, Raoult D. Vancomycin treatment of infective                       2010;44\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>AKKERMANSIA MUCINIPHILA<|>ORGANIZATION<|>Akkermansia muciniphila is a gut bacterium that plays a role in improving metabolic health and is associated with diet-induced obesity.)\n##\n(\"entity\"<|>GUT MICROBIOTA<|>ORGANIZATION<|>Gut microbiota refers to the complex community of microorganisms residing in the gastrointestinal tract, influencing various metabolic processes and health outcomes.)\n##\n(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a medical condition characterized by excessive body fat accumulation, which can lead to various health issues, including metabolic syndrome.)\n##\n(\"entity\"<|>DIETARY INTERVENTION<|>EVENT<|>Dietary intervention involves changes in diet aimed at improving health outcomes, particularly in relation to obesity and metabolic health.)\n##\n(\"entity\"<|>PERINATAL PROBIOTIC INTERVENTION<|>EVENT<|>Perinatal probiotic intervention refers to the administration of probiotics during the perinatal period to influence the development of obesity and metabolic health in infants.)\n##\n(\"relationship\"<|>AKKERMANSIA MUCINIPHILA<|>GUT MICROBIOTA<|>Akkermansia muciniphila is a component of the gut microbiota that has been linked to improved metabolic health and obesity management.<|>8)\n##\n(\"relationship\"<|>GUT MICROBIOTA<|>OBESITY<|>The gut microbiota plays a significant role in the development and management of obesity through its influence on metabolism.<|>7)\n##\n(\"relationship\"<|>DIETARY INTERVENTION<|>OBESITY<|>Dietary interventions are often implemented to combat obesity and improve metabolic health outcomes.<|>9)\n##\n(\"relationship\"<|>PERINATAL PROBIOTIC INTERVENTION<|>OBESITY<|>Perinatal probiotic interventions aim to prevent the development of obesity in infants by influencing gut microbiota from birth.<|>6)\n##\n(\"relationship\"<|>AKKERMANSIA MUCINIPHILA<|>DIETARY INTERVENTION<|>Akkermansia muciniphila has been shown to improve metabolic health during dietary interventions aimed at reducing obesity.<|>8)\n<|COMPLETE|>"}]}